Latest News

Why Lincoln Electric is back on investors’ radar Lincoln Electric Holdings (LECO) has drawn fresh attention after reporting fourth quarter and full year 2025 results, affirming a quarterly dividend of US$0.79 per share and continuing share repurchases. For many investors, that combination of recent earnings, ongoing cash returns and disciplined capital allocation raises practical questions about how the stock fits into an income plus growth oriented portfolio. See our latest analysis for...

Opera issues new 2026 revenue guidance Opera (NasdaqGS:OPRA) updated investors with fresh revenue guidance, projecting US$169 million to US$172 million for the first quarter of 2026 and US$720 million to US$735 million for the full year. See our latest analysis for Opera. At a share price of US$12.49, Opera has a 1 day share price return of 1.22% and a 7 day share price return of 2.04%. However, the 1 year total shareholder return shows a decline of 28.69% compared with a 3 year total...

Leadership change and why it matters for Dassault Systèmes stock Dassault Systèmes (ENXTPA:DSY) has entered a new chapter after co founder Bernard Charlès stepped down as Executive Chairman and board member for personal reasons. CEO Pascal Daloz now combines the Chairman and CEO roles. For investors, this consolidation of leadership focuses attention on how Daloz steers existing priorities around Industrial AI and the 3D UNIV+RSES platform, and whether the governance shift affects confidence,...

Host Hotels & Resorts, Inc. recently reported higher fourth-quarter and full-year 2025 revenue and net income, authorized a regular quarterly cash dividend of US$0.20 per share payable on April 15, 2026, confirmed 2026 earnings guidance, and completed a multi-year share repurchase program totaling 69,099,174 shares for US$1.15 billion. The company also sold the Four Seasons Resort Orlando at Walt Disney World Resort and the Four Seasons Resort and Residences Jackson Hole for US$1.10 billion,...

Euronet Worldwide, Inc. has reported its fourth-quarter and full-year 2025 results, with quarterly sales rising to US$1,108.7 million and net income reaching US$51.5 million, while full-year sales climbed to US$4,244.2 million and net income to US$309.5 million, all modestly higher than the prior year. Alongside these results, the company completed a large share repurchase program totaling 15,673,988 shares since 2022, reducing its share count by 35.01% and amplifying the effect of its...

Privia Health Group (PRVA) just released its fourth quarter and full year 2025 results, reporting higher sales and net income, and paired the update with 2026 GAAP revenue guidance in the US$2.35b to US$2.45b range. See our latest analysis for Privia Health Group. The earnings and revenue guidance appear to have shifted sentiment in the short term, with a 1 day share price return of 5.20% taking Privia Health Group to US$22.65. However, the 1 year total shareholder return of 11.04% and 3 year...

If you are trying to figure out whether MasTec at US$285.26 is still reasonably priced or starting to look stretched, you are in the right place. The stock has posted returns of 3.5% over the last 7 days, 14.8% over 30 days, 25.3% year to date, 124.9% over 1 year and 178.6% over 3 years, with a 5 year return of 228.9%. This naturally raises questions about what is already baked into the price. Recent news coverage around MasTec has focused on its role in capital goods and infrastructure...

In February 2026, The Macerich Company reported fourth-quarter 2025 results showing revenue of US$261.7 million and a net loss of US$18.76 million, while also declaring a quarterly dividend of US$0.17 per share payable on March 30, 2026. Alongside these results, Macerich highlighted record 2025 leasing activity and progress on its US$2.00 billion asset sale program, signaling meaningful execution on its portfolio reshaping plan. Next, we’ll examine how Macerich’s record leasing activity and...

Dorchester Minerals (DMLP) has wrapped up FY 2025 with fourth quarter revenue of US$41.9 million and EPS of US$0.32, capping a year in which trailing twelve month revenue was US$152.8 million and EPS reached US$1.16. Over the past few quarters the partnership has seen revenue move from US$32.8 million and EPS of US$0.29 in Q4 2024 to US$43.2 million with EPS of US$0.36 in Q1 2025, before settling at US$35.4 million and EPS of US$0.23 in Q3 2025. With a trailing net profit margin of 36.2% and...

Judo Capital Holdings Limited has reported its half-year results for the period ended December 31, 2025, with net interest income rising to A$235.5 million and net profit reaching A$59.9 million, both higher than the prior corresponding period. The uplift in both basic and diluted earnings per share from continuing operations suggests improving profitability as the bank scales its SME-focused lending model. We will now examine how this earnings uplift, particularly the increase in net...

United Laboratories International Holdings (SEHK:3933) and Novo Nordisk have reported Phase 2 data for obesity drug UBT251 in China, with plans to move into Phase 3 locally and to expand global studies. See our latest analysis for United Laboratories International Holdings. The Phase 2 obesity data arrives at a time when the share price has a HK$12.63 latest close and a 3 year total shareholder return above 200%. However, the 1 year total shareholder return of about a 5% decline suggests...

La-Z-Boy (LZB) is back in focus after quarterly results that topped Wall Street expectations on revenue and non GAAP profit, yet drew a negative stock reaction as investors weighed demand uncertainty and fresh tariff risks. See our latest analysis for La-Z-Boy. At a share price of US$35.92, La-Z-Boy has seen short term pressure, with a 30 day share price return of 6.26% decline and a 1 year total shareholder return of 19.43% decline, even though the 3 year total shareholder return sits at...

Protagonist Therapeutics (PTGX) is back in focus after fourth quarter results showed a net loss of US$44.38 million and missed revenue expectations, marking a shift from net income in the prior year period. See our latest analysis for Protagonist Therapeutics. Despite the disappointing quarter, Protagonist Therapeutics' share price has held relatively firm in the short term. It has a 7 day share price return of 4.95% and a 30 day share price return of 5.83%. Its 1 year total shareholder...

SBA Communications recently prepared to report earnings that analysts expect to show lower earnings per share than last year but higher revenues, with particular strength anticipated in international site leasing and development, while its CEO Brendan Cavanagh also spoke at Deutsche Bank’s 34th Annual Media, Internet and Telecom Conference in Palm Beach. This combination of shifting earnings expectations and emphasis on international growth priorities offers insight into how SBA is...

Woodside Energy Group recently reported full-year 2025 results showing sales of US$12.98 billion and net income of US$2.72 billion, alongside record production of 198.8 million barrels of oil equivalent and a final ordinary dividend of US$0.59 per share payable on March 27, 2026. Despite softer commodity prices weighing on profit compared with the prior year, investors are focused on Woodside’s record output, high project completion levels at Scarborough and Louisiana LNG, and the...

BWP Trust (ASX:BWP) has drawn fresh attention after releasing half year results showing higher sales, revenue and net income, together with reaffirmed full year distribution guidance that points to a 4.1% uplift in payouts. See our latest analysis for BWP Trust. These half year results and the reaffirmed distribution guidance come after a period where the share price has been relatively steady. The 1 month share price return was 2.93%, and the 1 year total shareholder return was 16.99%,...

What RLI’s Recent Trading Says About Investor Sentiment RLI Corp (RLI) has been drawing attention after its shares recently closed at US$61.65, with the stock showing a mix of positive short term performance and weaker returns over the past year. See our latest analysis for RLI. Short term momentum has been firmer, with a 1 month share price return of 5.42%. However, the year to date share price return shows a decline of 1.33%, and the 1 year total shareholder return reflects a loss of...

If you are wondering whether Xometry's share price still makes sense after recent swings, you are not alone. This article is going to focus squarely on what you are really paying for in the business. The stock last closed at US$41.82, with a 7 day return of 27.4% decline, a 30 day return of 34.7% decline, a year to date return of 33.4% decline, a 1 year return of 54.8%, and a 3 year return of 127.3%. Recent coverage has highlighted Xometry's position as an online marketplace for...

Third quarter results put U-Haul Holding (UHAL) fleet decisions in focus U-Haul Holding (UHAL) is back on investors’ radar after its 3Q FY2026 update, which combined modest 1.9% revenue growth with pressure on profitability from higher depreciation and losses on retired rental equipment. The self-storage business recorded 7.9% revenue growth, while earnings per share took a reported $0.24 hit from write downs and sales of older vehicles, particularly cargo vans. This has prompted management...

Affiliated Managers Group, Inc. reported higher fourth-quarter and full-year 2025 sales and net income, authorized a new share repurchase program of up to 4,200,000 shares, and declared a US$0.01 per-share cash dividend, while also announcing leadership changes including the planned retirement of director Karen L. Alvingham and the re-appointment of CEO Jay C. Horgen as President, alongside the upcoming departure of President and COO Thomas M. Wojcik. The addition of veteran asset manager G...

Why American Eagle Outfitters (AEO) Is On Investors’ Radar Today American Eagle Outfitters (AEO) has been drawing fresh attention as investors reassess the retailer’s recent share performance, with the stock showing mixed returns across the past week, month, and past 3 months. See our latest analysis for American Eagle Outfitters. At a share price of $24.04, American Eagle Outfitters has seen an 18.66% 90 day share price return, while the 1 year total shareholder return of 85.61% points to...

Why Clearwater Analytics Holdings (CWAN) is back on investors’ radar Clearwater Analytics Holdings (CWAN) has drawn fresh attention after its shares delivered a positive 3 month total return while still showing a loss over the past year, prompting investors to reassess the SaaS provider’s profile. See our latest analysis for Clearwater Analytics Holdings. The recent 8.15% 90 day share price return contrasts with a 1 year total shareholder return loss of 22.5%. Momentum has picked up in the...

Crinetics Pharmaceuticals (CRNX) is back in focus after recent clinical trial results and FDA review acceptance for its lead acromegaly therapy candidate Paltusotine. These developments sharpen attention on the company’s rare disease pipeline. See our latest analysis for Crinetics Pharmaceuticals. Crinetics’ recent trial readouts and the FDA’s acceptance of the Paltusotine filing come after a 30 day share price return of 17.38% decline and a 1 year total shareholder return of 33.30%, which...

What adidas (XTRA:ADS) investors can take from recent performance With no single headline event driving attention to adidas (XTRA:ADS) today, investors are instead weighing the stock’s recent share performance, earnings profile and valuation signals against its longer term track record. See our latest analysis for adidas. At a share price of €158.5, adidas has seen a 7.9% 1 month share price return, while the year to date share price return and 1 year total shareholder return are both...